Assessment and Management of Older Adults Undergoing PCI, Part 1: A JACC: Advances Expert Panel

Michael G Nanna1, Nadia R Sutton2,3, Ajar Kochar4

  • 1Yale University School of Medicine, New Haven, Connecticut, USA.

JACC. Advances
|August 16, 2023
PubMed

Insights

Older adults undergoing cardiac catheterization face high risks. A fourth pillar, geriatric syndromes, should be added to risk assessment to better identify patients who will benefit from procedures.

Area of Science:

  • Geriatric medicine
  • Cardiology
  • Interventional cardiology

Background:

  • Aging population increases referrals to cardiac catheterization labs.
  • Older adults have the highest risk of morbidity and mortality, especially after high-risk percutaneous coronary interventions.
  • Current risk assessment tools may not adequately capture risks in this demographic.

Purpose of the Study:

  • To highlight the importance of geriatric syndromes in risk assessment for older adults undergoing cardiac catheterization.
  • To propose an expanded risk assessment framework incorporating geriatric domains.

Main Methods:

  • Review of current risk assessment strategies for cardiac catheterization.
  • Identification of key geriatric syndromes relevant to cardiovascular procedures.
  • Proposal of a four-pillar risk assessment model.

Main Results:

  • Conventional risk assessment relies on cardiovascular, physiologic, hemodynamic, and anatomic/procedural factors.
  • Geriatric syndromes represent a critical, often overlooked, domain of risk in older adults.
  • These syndromes can significantly influence outcomes and may supersede other risk factors.

Conclusions:

  • A comprehensive risk assessment for older adults undergoing cardiac catheterization must include geriatric syndromes.
  • Integrating geriatric assessments can improve patient selection and optimize outcomes.
  • This expanded approach aims to ensure net benefit by accounting for unique geriatric vulnerabilities.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...